Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,571.3
31.9 (1.26%)

 

  • STI Straits Times Index
    2,571.3
    31.9 (1.26%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,358.4
    -11.3 (-0.83%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,300.3
    330.0 (1.38%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,795.7
    -30.2 (-1.07%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    19,498.5
    152.7 (0.79%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,649.1
    22.4 (0.48%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,524.5M
  • Value: 1,408.7M
  • Rise: 279
  • Fall: 74
  • Unch: 459

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.120+0.010
ESR-REIT0.280+0.025
Genting Sing0.725-0.020
Lippo Malls Tr0.103-0.003
Broadway Ind^0.087+0.002
CapitaMall Trust1.680-0.020
Singtel2.710+0.100
AusGroup^0.025+0.001
OEL0.020+0.001
Golden Agri-Res0.164+0.008

World Indices

World Indices
Name Last Change
Nasdaq 8,153.6 +62.7
HSI 24,300.3 +330.0
HSCEI 9,811.1 +129.2
Jakarta 4,649.1 +22.4
Nikkei 225 19,498.5 +152.7
SSE Comp 2,798.1 -27.8
Shanghai A 2,932.4 -29.2
Shanghai B 217.9 -1.8
KOSPI 1,859.7 +23.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

IDERA PHARMACEUTICALS INC IDERA PHARMACEUTICALS INC
Updated on 09 Apr 2020 (End of trading day)
Last (USD): 1.430 Change: -0.030 High: 1.510 Remarks: -
Change (%): -2.05 Low: 1.390
Open 1.500 Yesterday's Close 1.46
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 140,615 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a - Trailing EPS (USD) e - NAV (USD) b -
PE a - Trailing PE f - Price / NAV b -
Dividend (USD) d - Cash In Hand (USD) g 1.3075 Issued & Paid-up Shares c 30,607,000
Dividend Yield (%) d - Price / Cash In Hand g 1.094 Treasury Shares h -
Beta - 75 Daysi 1.069 R-Squared - 75 Days(%)i 31.78 Market Cap (M) 43.768
Beta - 500 Daysi 0.455 R-Squared - 500 Days (%)i 0.06 Enterprise Value (M) 2.037
Piotroski F Score 2 Exchange Code IDRA Par Value ( $ ) n.a.
52 Weeks Volatility (%) 79.69 Free Float (%) 87.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 25 Mar 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference IDERA PHARMACEUTICALS INC NASDAQ 43.768 - - - -
Industry Biotechnology NASDAQ 2,384.472 297.790 276.259 97.0085 0.808
Local Peer AMGEN INC NASDAQ 128,701.785 - - - 2.665
Local Peer GILEAD SCIENCES INC NASDAQ 92,549.825 - - - 3.447
Local Peer VERTEX PHARMACEUTICAL NASDAQ 63,938.328 - - - -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 56,435.844 - - - -
Local Peer BIOGEN INC NASDAQ 55,883.247 - - - -
Local Peer ILLUMINA INC NASDAQ 42,280.140 - - - -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 21,372.683 - - - -
Local Peer SEATTLE GENETICS INC NASDAQ 20,726.323 - - - -
Local Peer INCYTE CORPORATION NASDAQ 18,818.325 - - - -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 14,313.113 - - - -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 13,386.420 - 43.132 4.8432 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 13,159.319 - - - -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FIBROGEN INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), UNIQURE N.V. (NASDAQ), KODIAK SCIENCES INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALECTOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), EPIZYME INC (NASDAQ), ARVINAS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), VIELA BIO INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), REGENXBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), VERACYTE INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NEXTCURE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), OMEROS CORP (NASDAQ), PASSAGE BIO INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), RETROPHIN INC (NASDAQ), COMPUGEN (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ARDELYX INC (NASDAQ), AVROBIO INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ATHERSYS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), VERASTEM INC (NASDAQ), PRECIGEN INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ANAPTYSBIO INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AGENUS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), NANTKWEST INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), AVID BIOSERVICES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), ADURO BIOTECH INC (NASDAQ), GERON CORP (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), XOMA CORP (NASDAQ), RECRO PHARMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CABALETTA BIO INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), IVERIC BIO INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIASMA INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AFFIMED N V (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), INFLARX N V (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), VAXART INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ARAVIVE INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CHIMERIX INC (NASDAQ), VERMILLION INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), IMV INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), VACCINEX INC (NASDAQ), OTONOMY INC (NASDAQ), SESEN BIO INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), TREVENA INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), EQUILLIUM INC (NASDAQ), ADVAXIS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), RESTORBIO INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SOLIGENIX INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), ZAFGEN INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ATYR PHARMA INC (NASDAQ), TOCAGEN INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), CURIS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), OCUGEN INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), AIKIDO PHARMA INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 149,382.121 55.679 51.568 17.2728 0.806
Global Peer AMGEN-T HKEx 587,763.000 8.934 9.565 7.7984 4.433
Global Peer AGILENT TECHNOLOGIES INC NYSE 24,254.963 - 31.747 5.0031 0.836
Global Peer WUXI BIO HKEx 147,548.970 197.547 128.542 10.3177 -
Global Peer SINO BIOPHARM HKEx 141,904.374 13.243 46.102 4.0775 0.648
Global Peer BEIGENE HKEx 84,959.680 - - 11.3321 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 3,257.280 - - - -
Global Peer GENSCRIPT BIO HKEx 24,356.521 146.476 - 8.1658 -
Global Peer 3SBIO HKEx 21,932.467 14.498 19.979 2.0371 -
Other Global Peers ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), VIVA BIOTECH (HKEx), MYOVANT SCIENCES LTD (NYSE), POLYNOVO LIMITED (ASX), ARCUS BIOSCIENCES INC (NYSE), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), KADMON HLDGS INC (NYSE), MESOBLAST LTD (ASX), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), BBI LIFE SCI (HKEx), DPHARMA (Bursa), PFENEX INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), UNI-BIO GROUP (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), IBIO INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), IMUGENE LIMITED (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), BIOTRON (ASX), CT ENTERPRISE (HKEx), SYNTHETIC BIOLOGICS INC (NYSE American), IMMUTEP LTD (ASX), BIOSINO BIO-TEC (HKEx), ORAGENICS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), HOLISTA COLLTECH LIMITED (ASX), REGENT PACIFIC (HKEx), KAZIA THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), MEMPHASYS LTD (ASX), BIONOMICS LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), Suntar Eco-City^ (SGX), GENETIC TECHNOLOGIES (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), CCP TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HAO WEN HLDGS (HKEx), REGENEUS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), RHINOMED LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), BENITEC BIOPHARMA LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), ADALTA LTD (ASX), LEAF RESOURCES LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.180
+14.40 %
10 Days -+0.040
+2.88 %
20 Days -+0.370
+34.91 %
Medium Term Return 3 Months --0.395
-21.64 %
6 Months --1.050
-42.34 %
1 Year --1.380
-49.11 %
Long Term Return 2 Years --12.890
-90.01 %
3 Years --16.570
-92.06 %
5 Years --27.290
-95.02 %
Annualised Return Annualised --
-45.12 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.813 - 4.190 Change From 1 Year Low +0.617 % Change From 1 Year Low (%) +75.89
Change From 1 Year High -2.760 % Change From 1 Year High (%) -65.87
2 Years Range 0.813 - 17.120 Change From 2 Years Low +0.617 % Change From 2 Years Low (%) +75.89
Change From 2 Years High -15.690 % Change From 2 Years High (%) -91.65
5 Years Range 0.813 - 35.360 Change From 5 Years Low +0.617 % Change From 5 Years Low (%) +75.89
Change From 5 Years High -33.930 % Change From 5 Years High (%) -95.96
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
09 Apr 2020 1.500 1.510 1.390 1.430 140,615 -
08 Apr 2020 1.700 1.710 1.380 1.460 997,852 -
07 Apr 2020 1.320 1.370 1.215 1.240 178,664 -
06 Apr 2020 1.260 1.311 1.230 1.260 53,395 -
03 Apr 2020 1.250 1.290 1.180 1.230 49,877 -
02 Apr 2020 1.300 1.320 1.250 1.250 52,247 -
01 Apr 2020 1.250 1.320 1.250 1.280 50,837 -
31 Mar 2020 1.440 1.440 1.210 1.320 257,464 -
30 Mar 2020 1.470 1.470 1.360 1.420 43,784 -
27 Mar 2020 1.370 1.450 1.250 1.410 86,755 -
26 Mar 2020 1.290 1.450 1.250 1.390 230,938 -
25 Mar 2020 1.250 1.300 1.220 1.270 131,098 -
24 Mar 2020 1.270 1.290 1.200 1.210 244,371 -
23 Mar 2020 1.230 1.290 1.160 1.260 103,908 -
20 Mar 2020 1.220 1.300 1.200 1.230 98,469 -
19 Mar 2020 1.170 1.290 1.170 1.210 96,052 -
18 Mar 2020 1.200 1.200 1.050 1.130 69,143 -
17 Mar 2020 1.070 1.240 1.070 1.200 107,667 -
16 Mar 2020 0.813 1.150 0.813 1.070 135,935 -
13 Mar 2020 1.250 1.250 0.890 1.180 357,964 -
12 Mar 2020 1.300 1.300 1.030 1.060 309,782 -
11 Mar 2020 1.500 1.500 1.350 1.380 279,440 -
Summary
Current 2 Weeks
(27 Mar 2020 to 09 Apr 2020)
1.370 1.710 1.180 1.430 1,911,490 -
Previous 2 Weeks
(13 Mar 2020 to 26 Mar 2020)
1.250 1.710 0.890 1.390 1,575,545 -
4 Weeks from
(13 Feb 2020 to 12 Mar 2020)
1.580 1.710 1.180 1.060 4,167,236 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.